D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedulePresented positive 60-week ...

DermaRite Industries, LLC is recalling certain lots of DermaKleen, DermaSarra, KleenFoam, and PeriGiene skin products after ...

Reported 32-week data from Phase 2b RewinD-LB Trial Extension phase showing neflamapimod treatment resulted in a substantial reduction in clinically significant worsening compared to control arm over ...

Presentation of interim analysis from approximately 25 six-month evaluable BCG-Unresponsive patients in the ongoing ...

SEED Therapeutics, Inc. ("SEED”), a clinical-stage biotechnology company pioneering rational molecular glue degraders for ...

A new pill that combats antibiotic-resistant strains of gonorrhoea is closer to US approval, after the FDA accepted GSK’s gepotidacin for priority review.

Fran Lebowitz says she finds the idea of living with someone else ‘horrible’ ...

Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary ...

An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

The U.S. Postal Service has cracked down on distributors of unregulated vapes using its services for business shipments, ...

Four over-the-counter skincare products meant to help immunosuppressed individuals are being recalled after it was discovered ...